HER (erbB) tyrosine kinase inhibitors in the treatment of breast cancer

被引:82
作者
Arteaga, CL
Moulder, SL
Yakes, FM
机构
[1] Vanderbilt Univ, Sch Med, Dept Med, Div Oncol, Nashville, TN 37232 USA
[2] Vanderbilt Univ, Sch Med, Dept Canc Biol, Nashville, TN 37232 USA
[3] Vanderbilt Univ, Sch Med, Vanderbilt Ingram Canc Ctr, Nashville, TN 37232 USA
关键词
D O I
10.1053/sonc.2002.34047
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:4 / 10
页数:7
相关论文
共 44 条
[1]   Biologic effects of heregulin/neu differentiation factor on normal and malignant human breast and ovarian epithelial cells [J].
Aguilar, Z ;
Akita, RW ;
Finn, RS ;
Ramos, BL ;
Pegram, MD ;
Kabbinavar, FF ;
Pietras, RJ ;
Pisacane, P ;
Sliwkowski, MX ;
Slamon, DJ .
ONCOGENE, 1999, 18 (44) :6050-6062
[2]  
ALIMANDI M, 1995, ONCOGENE, V10, P1813
[3]   ZD1839 ('Iressa')1,2 as an anticancer agent [J].
Baselga, J ;
Averbuch, SD .
DRUGS, 2000, 60 (Suppl 1) :33-40
[4]   Oncogenic kinase signalling [J].
Blume-Jensen, P ;
Hunter, T .
NATURE, 2001, 411 (6835) :355-365
[5]   Employment of the epidermal growth factor receptor in growth factor-independent signaling pathways [J].
Carpenter, G .
JOURNAL OF CELL BIOLOGY, 1999, 146 (04) :697-702
[6]   HUMANIZATION OF AN ANTI-P185HER2 ANTIBODY FOR HUMAN CANCER-THERAPY [J].
CARTER, P ;
PRESTA, L ;
GORMAN, CM ;
RIDGWAY, JBB ;
HENNER, D ;
WONG, WLT ;
ROWLAND, AM ;
KOTTS, C ;
CARVER, ME ;
SHEPARD, HM .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1992, 89 (10) :4285-4289
[7]   Inhibitory Fc receptors modulate in vivo cytoxicity against tumor targets [J].
Clynes, RA ;
Towers, TL ;
Presta, LG ;
Ravetch, JV .
NATURE MEDICINE, 2000, 6 (04) :443-446
[8]   Multinational study of the efficacy and safety of humanized anti-HER2 monoclonal antibody in women who have HER2-overexpressing metastatic breast cancer that has progressed after chemotherapy for metastatic disease [J].
Cobleigh, MA ;
Vogel, CL ;
Tripathy, D ;
Robert, NJ ;
Scholl, S ;
Fehrenbacher, L ;
Wolter, JM ;
Paton, V ;
Shak, S ;
Lieberman, G ;
Slamon, DJ .
JOURNAL OF CLINICAL ONCOLOGY, 1999, 17 (09) :2639-2648
[9]   Cancer and genomics [J].
Futreal, PA ;
Kasprzyk, A ;
Birney, E ;
Mullikin, JC ;
Wooster, R ;
Stratton, MR .
NATURE, 2001, 409 (6822) :850-852
[10]   HETERODIMERIZATION OF THE ERBB-1 AND ERBB-2 RECEPTORS IN HUMAN BREAST-CARCINOMA CELLS - A MECHANISM FOR RECEPTOR TRANSREGULATION [J].
GOLDMAN, R ;
BENLEVY, R ;
PELES, E ;
YARDEN, Y .
BIOCHEMISTRY, 1990, 29 (50) :11024-11028